Related Experiment Video
Updated: May 12, 2026
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
Non-Gaussian diffusion MRI assessment of brain microstructure in mild cognitive impairment and Alzheimer's disease
Maria F Falangola1, Jens H Jensen, Ali Tabesh
1Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC 29425, USA. falangol@musc.edu
Abstract:
We report the first application of a novel diffusion-based MRI method, called diffusional kurtosis imaging (DKI), to investigate changes in brain tissue microstructure in patients with mild cognitive impairment (MCI) and AD and in cognitively intact controls. The subject groups were characterized and compared in terms of DKI-derived metrics for selected brain regions using analysis of covariance with a Tukey multiple comparison correction. Receiver operating characteristic (ROC) and binary logistic regression analyses were used to assess the utility of regional diffusion measures, alone and in combination, to discriminate each pair of subject groups. ROC analyses identified mean and radial kurtoses in the anterior corona radiata as the best individual discriminators of MCI from controls, with the measures having an area under the ROC curve (AUC) of 0.80 and 0.82, respectively. The next best discriminators of MCI from controls were diffusivity and kurtosis (both mean and radial) in the prefrontal white matter (WM), with each measure having an AUC between 0.77 and 0.79. Finally, the axial diffusivity in the hippocampus was the best overall discriminator of MCI from AD, having an AUC of 0.90. These preliminary results suggest that non-Gaussian diffusion MRI may be beneficial in the assessment of microstructural tissue damage at the early stage of MCI and may be useful in developing biomarkers for the clinical staging of AD.
Insights
Diffusional kurtosis imaging (DKI), a novel MRI method, shows promise in detecting early brain microstructural changes in mild cognitive impairment (MCI) and Alzheimer's disease (AD). Specific DKI metrics effectively differentiate between MCI and control groups, and aid in distinguishing MCI from AD.
Area of Science:
- Neuroimaging
- Biomarkers
- Neurology
Background:
- Mild cognitive impairment (MCI) and Alzheimer's disease (AD) involve progressive brain microstructural changes.
- Early detection and accurate staging of these conditions are crucial for effective management.
- Current diagnostic methods may not fully capture the subtle microstructural alterations in early-stage disease.
Purpose of the Study:
- To apply diffusional kurtosis imaging (DKI), a novel diffusion MRI technique, to assess brain tissue microstructure in individuals with MCI, AD, and healthy controls.
- To identify DKI-derived metrics that can effectively differentiate between these subject groups.
- To evaluate the utility of DKI metrics as potential biomarkers for the clinical staging of AD.
Main Methods:
- The study involved three groups: cognitively intact controls, patients with MCI, and patients with AD.
- Diffusional kurtosis imaging (DKI) was performed to acquire microstructural information.
- Analysis of covariance (ANCOVA) with Tukey correction and receiver operating characteristic (ROC) analyses were used to compare DKI metrics and assess their discriminatory power.
Main Results:
- Mean and radial kurtoses in the anterior corona radiata were the strongest individual predictors distinguishing MCI from controls (AUCs 0.80-0.82).
- Diffusivity and kurtosis measures in the prefrontal white matter also showed good discrimination between MCI and controls (AUCs 0.77-0.79).
- Axial diffusivity in the hippocampus was the most effective discriminator between MCI and AD (AUC 0.90).
Conclusions:
- Non-Gaussian diffusion MRI, specifically DKI, shows potential for assessing early microstructural tissue damage in MCI.
- DKI-derived metrics demonstrate utility in differentiating between cognitive states and may serve as biomarkers for clinical staging in AD.
- These findings highlight the value of advanced diffusion MRI techniques in neurodegenerative disease research.
